WIENER KLINISCHE WOCHENSCHRIFT, vol.125, pp.616-620, 2013 (SCI-Expanded)
The use of anti-TNF drugs for rheumatic diseases has increased in recent years. Several studies have reported an increased risk of reactivation of tuberculosis (TB) with anti-TNF agents.